(Press-News.org)
(MEMPHIS, Tenn. – September 23, 2025) Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes. However, adapting them for biomedical applications has been challenging. To address this limitation, scientists at St. Jude Children’s Research Hospital designed a screening approach to measure efficiency and specificity for thousands of CAST variants accurately. This high-throughput approach allowed the researchers to rapidly optimize promising candidate CASTs, uncovering mechanistic insights fundamental for further engineering and potential clinical use. The findings were published today in Nucleic Acid Research.
Discovered in 2017, CASTs integrate large pieces of DNA into the genome at locations defined by a given RNA sequence. They are highly specific in bacteria, their natural host, but they do not work as well in human cells.
For this reason, corresponding author Elizabeth Kellogg, PhD, St. Jude Department of Structural Biology, is keenly interested in engineering CASTs to be more applicable to humans and other organisms. To do so requires a quick way to evaluate the strengths and weaknesses of engineered CASTs.
“One major gap in understanding CASTs was not just measuring their overall activity, but also how accurately they integrate DNA at the intended locations,” Kellogg said. “There simply wasn’t a scalable way to characterize their specificity.”
CASTing call for specificity and efficiency
To address this gap, the researchers devised a high-throughput screen to measure the relative activity and specificity of thousands of CAST variants in a single experiment. By focusing on a single subtype — the V-K CAST, which is notably less complex than others — they were able to make slight alterations to its proteins and rapidly screen the mutants.
“We wanted to screen a library with every possible single mutation to explore the mutational landscape of a CAST system,” said co-first author Seong Guk Park, PhD, Department of Structural Biology. “We didn’t focus on specific regions; instead, we tested them all to find mutations that could improve activity or specificity.”
After the V-K CAST mutational screening, the researchers combined several of the most promising mutations to see if their positive effect was additive. “With just a few mutations, activity increased fivefold,” Kellogg said. “We improved both specificity and activity without compromising either, which was not possible with previous strategies.”
Kellogg will continue working to improve the CAST design. With this screen now available, she is optimistic. “The natural system is very complicated, so we need to develop more minimal systems,” Kellogg said. “But this screen now enables us to be more ambitious with our protein design so that we can ultimately achieve this goal.”
Authors and funding
The study’s other first author is Jung-Un Park, University of California Berkeley and St. Jude. The study’s other authors are Esteban Dodero-Rojas, John Bryant Jr., and Geetha Sankaranarayanan, St. Jude.
The study was supported by the National Institutes of Health (5R01GM144566-02), the Pew Charitable Trusts, the Cystic Fibrosis Foundation, the Jane Coffin Childs Memorial Fund, the Korea Health Industry Development Institute (HI19C1095), the National Cancer Institute (P30-CA21765) and the American Lebanese Syrian Associated Charities (ALSAC), the fundraising and awareness organization of St. Jude.
St. Jude Media Relations Contact
Chelsea Bryant
Desk: (901) 595-0564
Cell: (256) 244-2048
chelsea.bryant@stjude.org
media@stjude.org
St. Jude Children’s Research Hospital
St. Jude Children’s Research Hospital is leading the way the world understands, treats, and cures childhood catastrophic diseases. From cancer to life-threatening blood disorders, neurological conditions, and infectious diseases, St. Jude is dedicated to advancing cures and means of prevention through groundbreaking research and compassionate care. Through global collaborations and innovative science, St. Jude is working to ensure that every child, everywhere, has the best chance at a healthy future. To learn more, visit stjude.org, read St. Jude Progress, a digital magazine, and follow St. Jude on social media at @stjuderesearch.
END
Drinking any amount of alcohol likely increases the risk of dementia, suggests the largest combined observational and genetic study to date, published online in BMJ Evidence Based Medicine.
Even light drinking—generally thought to be protective, based on observational studies—is unlikely to lower the risk, which rises in tandem with the quantity of alcohol consumed, the research indicates.
Current thinking suggests that there might be an ‘optimal dose’ of alcohol for brain health, but most of these studies have focused on older people and/or didn’t differentiate between former and lifelong non-drinkers, complicating efforts ...
BMJ Group has retracted research suggesting that small daily quantities of apple cider vinegar might help people who are overweight or obese to lose weight.
The small clinical trial was published in the open access journal BMJ Nutrition, Prevention & Health in March 2024 and its findings press released. The study findings generated widespread international attention at the time, and continue to be frequently referred to in media coverage.
The retraction was prompted by concerns raised about the quality of the work, ...
There’s been a significant rise in the use of low and alcohol-free drinks to curb alcohol intake among ‘risky drinkers’ over the past 5 years in England, Wales, and Scotland, finds research published in the open access journal BMJ Public Health.
The proportion of those using them to make serious attempts to cut down their alcohol intake rose from 35% in 2020 to 44% in 2024, while those using them in any attempt to cut down increased from 26% to 39%.
The trends were especially noticeable ...
Frequent exercise doesn’t just strengthen the heart – it also changes the nerves that control it, according to new research which could guide more targeted and effective care for common heart problems.
The study, led by the University of Bristol (UK), shows for the first time that moderate aerobic training reshapes nerves that drive the heart, and affects them on each side of the heart differently. The research is published in the journal Autonomic Neuroscience today (Wednesday, 24 September).
Findings ...
Saturday 27th September marks the centenary of the birth of Sir Robert Edwards, who with colleagues Patrick Steptoe and Jean Purdy oversaw the conception and birth of the world’s first IVF baby in 1978.(1) It was a breakthrough in reproductive medicine which would bring immeasurable benefits to people with infertility and whose demographic importance today is greater than ever.
Now, from various reports published by this journal, we can confidently say that the global impact of IVF continues to grow in terms of children conceived and the extent of its use. There are few causes of infertility which today are not amenable to treatment while ...
(Barcelona, Spain, Wednesday, 24 September 2025) New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.1
Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, was evaluated using real-world data from three large MS registries: MSBase, OFSEP, and the Danish MS Registry. The analysis compared ocrelizumab-treated patients ...
BETHESDA, MD – The Biophysical Society is pleased to announce that Wonhwa Cho, of the University of Illinois Chicago, USA, has been named the recipient of the 2026 BPS Award in the Biophysics of Health and Disease. Cho will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Cho will be recognized for mechanistic elucidation of lipid-protein interactions foundational to lipid-targeted drug discovery.
“Wonhwa has pioneered new and innovative experimental approaches to overcome obstacles ...
You can’t see nanoplastics with the naked eye, but they’re everywhere — including your body.
Tinier than the better-known microplastics, these plastic particles range from one nanometer to one micrometer in size; a human hair, by comparison, is about 100 micrometers thick.
“Nanoplastics are present in drinking water, food and the air, and have been detected in both tap water and bottled water,” explained Binghamton University Assistant Professor of Chemistry Huiyuan Guo. “They are widely detected in the environment.”
Guo and Associate Professor of Biological Sciences ...
BETHESDA, MD – The Biophysical Society is pleased to announce that Erdinc Sezgin, of SciLifeLab, Karolinska Institutet, Sweden, has been named the recipient of the 2026 Early Independent Career Award. Sezgin will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Sezgin will be recognized for combining chemistry, physics, biology and computer science to gain fundamental and translational insights into how the biophysics of cells affect health and disease.
“I am delighted that Erdinc ...
BETHESDA, MD – The Biophysical Society is pleased to announce that Charles L. Brooks III, of the University of Michigan, USA, has been named the recipient of the 2026 Klaus Schulten and Zaida Luthey-Schulten Computational Biophysics Lecture Award. Brooks will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Brooks will be recognized for his pioneering work in protein folding, free energy methods and service to the field of biophysics.
“Charles’ work leads the field not only in methodological ...
